Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial FibrillationDavid B. DeLurgio, Hugh Calkins, Karl J. Crossen et al.|Circulation Arrhythmia and Electrophysiology|2020Cited by 246
Convergence of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Persistent AF (CONVERGE Trial): Rationale and designDavid B. DeLurgio, Karl J. Crossen, Edward Ferguson et al.|American Heart Journal|2020Cited by 28
Prospective US investigational device exemption trial of a sutureless aortic bioprosthesis: One-year outcomesRakesh M. Suri, Eric E. Roselli, Héctor I. Michelena et al.|Journal of Thoracic and Cardiovascular Surgery|2018Cited by 24
Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: A subanalysis of the CONVERGE TrialDavid B. DeLurgio, Jaswinder Gill, Christopher Blauth et al.|Heart Rhythm O2|2022Cited by 19
Atrial fibrillation symptom reduction and improved quality of life following the hybrid convergent procedure: a CONVERGE trial subanalysisJaswinder Gill, David B. De Lurgio, Karl J. Crossen et al.|Annals of Cardiothoracic Surgery|2024Cited by 4